.

.


The information on this site is from academic and research studies. Applicability to humans must be determined by a licensed medical professional.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001.
    Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother ) Vol: 47 Issue 5 Pages: 1672-80
    Pub: 2003 May Epub:
    • Karlowsky JA
    • Jones ME
    • Thornsberry C
    • Friedland IR
    • Sahm DF

  2. Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review.
    Open forum infectious diseases (Open Forum Infect Dis ) Vol: 2 Issue 4 Pages: ofv178
    Pub: 2015 Dec Epub: 2015 Nov 25
    • Carris NW
    • Pardo J
    • Montero J
    • Shaeer KM

  3. Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung.
    Thorax (Thorax ) Vol: 72 Issue 1 Pages: 13-22
    Pub: 2017 Jan Epub: 2016 Aug 2
    • Segal LN
    • Clemente JC
    • Wu BG
    • Wikoff WR
    • Gao Z
    • Li Y
    • Ko JP
    • Rom WN
    • Blaser MJ
    • Weiden MD

  4. In vitro potentiation of carbapenems with tannic acid against carbapenemase-producing enterobacteriaceae: exploring natural products as potential carbapenemase inhibitors.
    Journal of applied microbiology (J Appl Microbiol ) Vol: 126 Issue 2 Pages: 452-467
    Pub: 2019 Feb Epub: 2018 Nov 23
    • Somboro AM
    • Osei Sekyere J
    • Amoako DG
    • Kumalo HM
    • Khan R
    • Bester LA
    • Essack SY

  5. A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin.
    Microbiology (Reading, England) (Microbiology ) Vol: 156 Issue Pt 11 Pages: 3354-9
    Pub: 2010 Nov Epub: 2010 Aug 19
    • Tannock GW
    • Munro K
    • Taylor C
    • Lawley B
    • Young W
    • Byrne B
    • Emery J
    • Louie T

  6. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection.
    Infection and immunity (Infect Immun ) Vol: 76 Issue 10 Pages: 4726-36
    Pub: 2008 Oct Epub: 2008 Aug 4
    • Sekirov I
    • Tam NM
    • Jogova M
    • Robertson ML
    • Li Y
    • Lupp C
    • Finlay BB

  7. The Effects of Inulin on Characteristics of Lactobacillus paracasei TD3 (IBRC-M 10784) as Probiotic Bacteria in vitro.
    Archives of Iranian medicine (Arch Iran Med ) Vol: 19 Issue 2 Pages: 92-5
    Pub: 2016 Feb Epub:
    • Mahboubi M
    • Kazempour N

  8. Different Dynamic Patterns of ß-Lactams, Quinolones, Glycopeptides and Macrolides on Mouse Gut Microbial Diversity.
    PloS one (PLoS One ) Vol: 10 Issue 5 Pages: e0126712
    Pub: 2015 Epub: 2015 May 13
    • Yin J
    • M P
    • Wang S
    • Liao SX
    • Peng X
    • He Y
    • Chen YR
    • Shen HF
    • Su J
    • Chen Y
    • Jiang YX
    • Zhang GX
    • Zhou HW

  9. Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach
    Clinical and Experimental Gastroenterology (Clin Exp Gastroenterol ) Vol: 8 Issue Pages: 309-325
    Pub: 2015 Dec 4 Epub: 2015 Dec 4
    • Soldi S
    • Vasileiadis S
    • Uggeri F
    • Campanale M
    • Morelli L
    • Fogli MV
    • Calanni F
    • Grimaldi M
    • Gasbarrini A

  10. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother ) Vol: 17 Issue 2 Pages: 273-9
    Pub: 1980 Feb Epub:
    • Hall WH
    • Opfer BJ
    • Gerding DN

Full list available by paid subscriptions

For More information see this summary.